Early clinical features of Parkinson’s disease and related disorders

Published on July 1, 2014   36 min

You are viewing a talk that is a part of one of our comprehensive courses. Additional learning material: case studies, projects, workshops and recommended reading; multiple choice questions and suggested exam questions with model answers are available on application. Learn more

Other Talks in the Series: The Genetic Basis of Neurological Disorders

Hello. My name is Alastair Noyce. I'm a clinician and researcher with a particular interest in Parkinson's disease and related neurodegenerative diseases. Moreover, I'm interested in the risk factors and earliest features of disease and how these can be used to find groups of people in the earliest stages so they might be recruited to clinical trials of neuroprotective drugs. I lead a project called PREDICT-PD which aims to find people at risk of Parkinson's disease or in the earliest stages of disease, and I'll speak more about this in due course.
These are my declarations and where I receive research funding from.
Topics for discussion. This lecture will concentrate on the early clinical features of Parkinson's disease primarily and finish with discussion about the early features of Parkinson's plus conditions including multiple system atrophy and progressive supranuclear palsy. The talk will follow the slides on screen. The slides will referr to past and current research, providing references for the studies discussed. At the outset I should say this is a very large field of research, and this talk aims to provide an overview rather than be all-encompassing. In addition, this is an area of research where many questions still remain, and so I've tried to focus on those aspects for which the best evidence exists.

Early clinical features of Parkinson’s disease and related disorders

Embed in course/own notes